Although research on NAD+ supps in humans is still in its infancy ... “Oral supplements in capsule or tablet form containing NR or NMN are widely available and convenient to use,” Ma says.
In a report released today, Jack Dunn CFA from Citi maintained a Buy rating on Mcmillan Shakespeare Limited (NMN – Research Report), with a price target of A$20.05. The company’s shares closed ...